APA (7th ed.) Citation

Ando, K., Ndjim, M., Turbant, S., Fontaine, G., Pregoni, G., Dauphinot, L., . . . Deramecourt, V. (2020). The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer's disease. Acta Neuropathologica Communications, 8(1), 1. https://doi.org/10.1186/s40478-020-00954-1

Chicago Style (17th ed.) Citation

Ando, Kunie, et al. "The Lipid Phosphatase Synaptojanin 1 Undergoes a Significant Alteration in Expression and Solubility and Is Associated with Brain Lesions in Alzheimer's Disease." Acta Neuropathologica Communications 8, no. 1 (2020): 1. https://doi.org/10.1186/s40478-020-00954-1.

MLA (9th ed.) Citation

Ando, Kunie, et al. "The Lipid Phosphatase Synaptojanin 1 Undergoes a Significant Alteration in Expression and Solubility and Is Associated with Brain Lesions in Alzheimer's Disease." Acta Neuropathologica Communications, vol. 8, no. 1, 2020, p. 1, https://doi.org/10.1186/s40478-020-00954-1.